Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 214 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 7/19/2007


21.		Phase III Chemotherapy with BCNU/CTX/VBL/PCB/PRED/BLEO Alternating with ADR/DTIC/BLEO for Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-75HD301 SEG-366, SEG-75HD0103


22.		Phase III Chemotherapy with BCNU/CTX/VBL/PCB/PRED with or without Radiotherapy for Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-77HD320 SEG-77HD0103


23.		Phase III Chemotherapy with MOPP plus BLEO vs MOPP plus ADR/BLEO for Remission Induction of Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7406 MDAR-117

Last Modified: 7/1/1997


24.		Radiotherapy plus Chemotherapy with NM/VCR/PCB/PRED/BLEO vs Chemotherapy for Stage III A & B Hodgkin's Disease - A Phase III Study (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7518 MDAR-24

Last Modified: 7/9/2007


25.		Phase III Radiotherapy, Dexamethasone Therapy, and Chemotherapy with BCNU, DTIC or Procarbazine for Malignant Glioma of the Brain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7703


26.		Phase III Chemotherapy with NM/VCR/PCB/PRED and Low-Dose BLEO for Hodgkin's Disease Stages IIIB, IVA and IVB

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				SWOG-774/775


27.		Phase III Evaluation of Chemotherapy with MOPP vs Chemotherapy with CCNU/VBL/PRED for Adult Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 18								WCG-130


28.		Phase III Combination Chemotherapy with MOPP (NM/VCR/PCB/PRED) Adjuvant to Radiotherapy for Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 61								WCG-135


29.		Phase III CVPP (CCNU/VBL/PCB/PRED) Alone or in Combination with Involved or Extended Field Radiotherapy for Stage I/II Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 16				NCI				CLB-7751

Last Modified: 5/23/2007


30.		Phase III CAMP (CTX/ADR/MTX/PCB) vs MVP (MITO/VBL/CACP) vs DAVA/CACP vs VP-16/CACP for Metastatic non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				EST-1581

Select All on One Page


					< Previous 1 2 3 4 5 6 Next >

| | | | | | | |

A Service of the National Cancer Institute